Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Ma...

FDA Recall #D-0580-2024 — Class III — June 18, 2024

Recall #D-0580-2024 Date: June 18, 2024 Classification: Class III Status: Terminated

Product Description

Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India, NDC 16729-533-08, UPC Code: 031672953308

Reason for Recall

Subpotent drug: out of specification results

Recalling Firm

Accord Healthcare, Inc. — Durham, NC

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

52,998

Distribution

USA Nationwide

Code Information

Lot# R2200834, R2200835, R2200841, R2200958, Exp 06/30/2024; R2201044 R2201045 R2201046, R2201047, R2201095, R2201142, R2201143, R2201144, Exp 07/31/2024; M2215870, M2215918, Exp 10/2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated